Chiorescu S, Andercou OA, Grad NO, Mironiuc IA. Intraperitoneal Administration of Rosuvastatin Prevents Postoperative Peritoneal Adhesions by Decreasing the Release of Tumor Necrosis Factor. Med Pharm Rep [Internet]. 2018 Jan. 30 [cited 2025 Oct. 6];91(1):79-84. Available from: https://medpharmareports.com/index.php/mpr/article/view/859